| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $19.8M | -13.7% |
| SG&A Expense | $10.1M | +6.1% |
| Operating Income | -$29.9M | +7.9% |
| Interest Expense | $1.2M | -3.2% |
| Pre-tax Income | -$29.2M | +14.1% |
| Income Tax | -$36K | -71.4% |
| Net Income | -$29.2M | +14.1% |
| EPS (Basic) | -$0.45 | +69.8% |
| EPS (Diluted) | -$0.45 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.6M | -65.8% |
| Short-term Investments | $107.9M | — |
| Current Assets | $122.6M | +223.0% |
| Total Assets | $123.0M | +219.7% |
| Current Liabilities | $13.4M | +5.3% |
| Total Liabilities | $15.6M | -27.3% |
| Stockholders' Equity | $107.5M | +529.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.2M | +2.7% |
| Capital Expenditures | $159K | — |
| Investing Cash Flow | -$107.4M | — |
| Financing Cash Flow | $111.3M | +435.8% |
| Free Cash Flow | -$28.3M | — |
| +69.8% |